We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > ESR

News List

U.S. Economy Again Limited By COVID And Supply Chain Concerns prnewswire
August 20, 2021
The full-year 2021 real GDP growth forecast was revised modestly downward due in part to the expectation that COVID-related disruptions to consumer spending and supply chains will more greatly hinder economic activity in the second half of the year.
Hearing loss and inner ear disorders: The next frontier for pharmaceutical success? pharmafile
October 31, 2018
Nawal Ouzren, CEO of Sensorion, examines the latest therapies and developments emerging in the difficult-to-treat world of human ear disorders, which paint a promising picture for patients with such conditions.
ESR plans investment in biotech start-up biospectrumasia
September 22, 2017
ABL’s intellectual property originated at Victoria University, and Viclink (Victoria’s commercialisation arm), is the major shareholder in ABL.